No Data
No Data
Windtree Announces Istaroxime Presentation By Cardiogenic Shock Thought Leader At Cardiovascular Clinical Trials Conference
Express News | Windtree Announces Istaroxime Presentation by Cardiogenic Shock Thought Leader at Cardiovascular Clinical Trials Conference
Windtree Announces New Istaroxime Patent Filing for Preventing or Reducing the Risk of Acute Myocardial Arrhythmia
H.C. Wainwright Maintains Windtree Therapeutics(WINT.US) With Hold Rating
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Sector Update: Health Care Stocks Mixed Wednesday Afternoon
Unlock the Full List